173 related articles for article (PubMed ID: 24812030)
1. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.
Karagiannis GS; Treacy A; Messenger D; Grin A; Kirsch R; Riddell RH; Diamandis EP
Mol Oncol; 2014 Oct; 8(7):1240-52. PubMed ID: 24812030
[TBL] [Abstract][Full Text] [Related]
2. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
4. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
Forse CL; Rahimi M; Diamandis EP; Assarzadegan N; Dawson H; Grin A; Kennedy E; O'Connor B; Messenger DE; Riddell RH; Kirsch R; Karagiannis GS
Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573
[TBL] [Abstract][Full Text] [Related]
5. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.
Karagiannis GS; Musrap N; Saraon P; Treacy A; Schaeffer DF; Kirsch R; Riddell RH; Diamandis EP
Biol Chem; 2015 Feb; 396(2):163-83. PubMed ID: 25153376
[TBL] [Abstract][Full Text] [Related]
7. Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study.
Fajardo M; Liu CJ; Egol K
Clin Orthop Relat Res; 2009 Dec; 467(12):3071-8. PubMed ID: 19597895
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
10. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.
Karagiannis GS; Petraki C; Prassas I; Saraon P; Musrap N; Dimitromanolakis A; Diamandis EP
Oncotarget; 2012 Mar; 3(3):267-85. PubMed ID: 22408128
[TBL] [Abstract][Full Text] [Related]
11. Analysis of spatial and temporal expression patterns of bone morphogenetic protein family members in the rat uterus over the estrous cycle.
Erickson GF; Fuqua L; Shimasaki S
J Endocrinol; 2004 Aug; 182(2):203-17. PubMed ID: 15283681
[TBL] [Abstract][Full Text] [Related]
12. Expression of the BMP-2, -4 and -7 and their antagonists gremlin, chordin, noggin and follistatin during ectopic osteogenesis.
Dudarić L; Cvek SZ; Cvijanović O; Santić V; Marić I; Crncević-Orlić Z; Bobinac D
Coll Antropol; 2013 Dec; 37(4):1291-8. PubMed ID: 24611347
[TBL] [Abstract][Full Text] [Related]
13. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
Sneddon JB; Zhen HH; Montgomery K; van de Rijn M; Tward AD; West R; Gladstone H; Chang HY; Morganroth GS; Oro AE; Brown PO
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14842-7. PubMed ID: 17003113
[TBL] [Abstract][Full Text] [Related]
15. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
Ahn J; Serrano de la Pena L; Shore EM; Kaplan FS
J Bone Joint Surg Am; 2003 Apr; 85(4):667-74. PubMed ID: 12672843
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
[TBL] [Abstract][Full Text] [Related]
17. The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study.
Tardif G; Pelletier JP; Boileau C; Martel-Pelletier J
Osteoarthritis Cartilage; 2009 Feb; 17(2):263-70. PubMed ID: 18691909
[TBL] [Abstract][Full Text] [Related]
18. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
19. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset.
Chalazonitis A; D'Autréaux F; Guha U; Pham TD; Faure C; Chen JJ; Roman D; Kan L; Rothman TP; Kessler JA; Gershon MD
J Neurosci; 2004 Apr; 24(17):4266-82. PubMed ID: 15115823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
